Analyst Ratings

Date	Action	Analyst	Rating	Target
May-13-26	Upgrade	Oppenheimer	Perform → Outperform	$115
Feb-23-26	Reiterated	Raymond James	Outperform	$95 → $101
Feb-20-26	Upgrade	Benchmark	Hold → Buy
Dec-18-25	Reiterated	Truist Financial		$86 → $95
Nov-24-25	Reiterated	Truist Financial		$88 → $86
Oct-24-25	Reiterated	Truist Financial		$121 → $88
Oct-24-25	Downgrade	Benchmark	Buy → Hold
Oct-24-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-24-25	Downgrade	Citigroup	Buy → Neutral
Oct-24-25	Reiterated	Piper Sandler	Overweight	$82

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023
Total Revenue	1,851	1,846	1,717	Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A	1,419	1,421	1,255
Gross Profit	431	426	461
Selling, General and Administrative Excl. Other	177	163	184
Research and Development	51	46	53
Other Operating Expense	11	8	16
Operating Income	193	209	208
Interest Expense	38	42	56
Unusual Expense	—	—	—
Non-Operating Income (Expense)	-5	42	-15
Net Income Before Taxes	159	125	148
Income Taxes	17	23	27
Consolidated Net Income	143	103	120
Net Income From Continuing Operations	143	103	121
Net Income	143	103	120
EPS (Recurring)	4.06	2.96	3.60
EPS (Basic, Before Extraordinaries)	4.06	2.96	3.60
EPS (Diluted)	4.01	2.89	3.40
EBITDA	333	294	333
Other After Tax Adjustments	—	—	—
Stock Option Compensation Expense	—	—	—
Price To Earnings Ratio	22.68	27.14	—
Price To Sales Ratio	1.67	1.49	—
Gross Margin	23.28	23.08	26.85
Operating Margin	10.43	11.32	12.11
Net Margin	7.73	5.58	6.99
Shares Outstanding	34	35	34
Market Capitalization	3,093	2,745	—
Operating Lease Expense	—	—	—

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stephens Jim	President, CRM & Neuro	May 15 '26	Option Exercise	0.00	3,435	0	6,331	May 19 12:00 AM
Smith Diron	EVP, Chief Financial Officer	May 08 '26	Option Exercise	0.00	4,126	0	13,422	May 12 12:00 AM
Harris John A	EVP, Global Ops and Manufactur	Mar 31 '26	Option Exercise	0.00	7,674	0	10,499	Apr 02 12:00 AM
Carr Terence	EVP, Qlty & Regulatory Affairs	Mar 24 '26	Option Exercise	0.00	2,700	0	2,702	Mar 25 12:00 AM
Blackwood Lindsay K.	SVP, Gen Counsel & Secretary	Mar 24 '26	Option Exercise	0.00	6,966	0	3,556	Mar 25 12:00 AM
Thomas Tommy P	VP, Corporate Controller	Mar 13 '26	Sale	85.00	825	70,125	4,381	Mar 17 12:00 AM
Khales Payman	President & CEO	Feb 24 '26	Option Exercise	0.00	70,043	0	78,799	Feb 24 12:00 AM
Thomas Tommy P	VP, Corporate Controller	Jan 20 '26	Option Exercise	0.00	674	0	4,391	Jan 21 12:00 AM
Smith Diron	EVP, Chief Financial Officer	Jan 20 '26	Option Exercise	0.00	584	0	11,058	Jan 21 12:00 AM
Khales Payman	President & CEO	Jan 20 '26	Option Exercise	0.00	2,696	0	26,434	Jan 21 12:00 AM
Thor Kirk K	Chief Human Resources Officer	Jan 20 '26	Option Exercise	0.00	1,632	0	28,750	Jan 21 12:00 AM
Senn Andrew	SVP, Strategy and Business Dev	Jan 20 '26	Option Exercise	0.00	4,448	0	12,625	Jan 21 12:00 AM
Thomas Tommy P	VP, Corporate Controller	Jan 19 '26	Option Exercise	0.00	480	0	4,054	Jan 21 12:00 AM
Harris John A	EVP, Global Ops and Manufactur	Jan 19 '26	Option Exercise	0.00	1,272	0	7,214	Jan 21 12:00 AM
Smith Diron	EVP, Chief Financial Officer	Jan 19 '26	Option Exercise	0.00	3,418	0	10,766	Jan 21 12:00 AM


Market Cap	3.04B	Forward P/E	13.36	EPS next Y	6.81	Insider Trans	0.39%	Shs Float	-	Perf Month	0.57%


Enterprise Value	4.41B	PEG	0.28	EPS next Q	1.38	Inst Own	-	Short Float	-	Perf Quarter	7.82%


Income	140.40M	P/S	1.64	EPS this Y	51.68%	Inst Trans	-	Short Ratio	-	Perf Half Y	23.09%


Sales	1.85B	P/B	1.81	EPS next Y	11.92%	ROA	4.16%	Short Interest	-	Perf YTD	15.98%


Book/sh	49.99	P/C	16.18	EPS next 5Y	10.78%	ROE	8.23%	52W High	123.77 -26.51%	Perf Year	-23.60%


Cash/sh	0.24	P/FCF	30.45	EPS past 3/5Y	-	ROIC	5.35%	52W Low	62.00 46.71%	Perf 3Y	-


Dividend Est.	-	EV/EBITDA	13.27	Sales past 3/5Y	11.52% 11.46%	Gross Margin	23.31%	Volatility	1.63% 1.85%	Perf 5Y	-


Dividend TTM	-	EV/Sales	2.39	EPS Y/Y TTM	85.29%	Oper. Margin	10.41%	ATR (14)	2.53	Perf 10Y	-


Dividend Ex-Date	-	Quick Ratio	2.38	Sales Y/Y TTM	7.80%	Profit Margin	7.67%	RSI (14)	52.45	Recom	2.29


Dividend Gr. 3/5Y	-	Current Ratio	3.75	EPS Q/Q	-8.40%	SMA20	0.12%	Beta	0.70	Target Price	108.00


Payout	0.00%	Debt/Eq	0.81	Sales Q/Q	0.92%	SMA50	2.66%	Rel Volume	1.11	Prev Close	89.50


Employees	11,000	LT Debt/Eq	0.79	Earnings	Jul 23	SMA200	5.62%	Avg Volume	522.74K	Price	90.96


IPO Date	Sep 29, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.83% 3.29%	Net Debt/EBITDA	4.13	Volume	581,346	Change	1.63%

ITGR